INTERCEPT PHARMACEUTICALS IN (ICPT) Stock Analyst Earnings Estimates
NASDAQ:ICPT - Nasdaq - US45845P1084 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 312.7M 24.09% | 260.75M -16.61% | 285.71M 9.57% | 337.77M 18.22% | 368.48M 9.09% | 368.73M 0.07% | 370.63M 0.52% | 354.64M -4.31% | 344.04M -2.99% | 287.77M -16.36% | 334.33M 16.18% | |
| EBITDA YoY % growth | -215.48M 30.21% | -97.876M 54.58% | -67.624M 30.91% | -45.877M 32.16% | 103M 324.51% | 47.371M -54.01% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -218.6M 30.03% | -100.69M 53.94% | -68.216M 32.25% | -45.946M 32.65% | 102.71M 323.54% | 107.98M 5.13% | 116.5M 7.89% | 101.85M -12.58% | 97.124M -4.64% | 33.03M -65.99% | 43.142M 30.61% | |
| Operating Margin | -69.91% | -38.62% | -23.88% | -13.60% | 27.87% | 29.28% | 31.43% | 28.72% | 28.23% | 11.48% | 12.90% | |
| EPS YoY % growth | -7.97 26.81% | -3.41 57.21% | 6.04 277.13% | -1.33 -122.07% | 2.09 256.55% | 1.77 -15.32% | 1.70 -3.79% | 1.65 -3.16% | 1.56 -5.00% | 0.43 -72.39% | 0.58 34.66% |
All data in USD
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.03 105.54% | 0.20 125.62% | 0.51 461.59% | 0.61 657.77% | 0.65 2,259.76% | 0.29 49.43% | 0.37 -27.06% | 0.27 -55.58% | 0.15 -76.89% |
| Revenue Q2Q % growth | 92.785M 20.16% | 83.794M 23.30% | 92.679M 10.70% | 94.418M 6.34% | 97.074M 4.62% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 1.663M 109.56% | 8.14M 125.81% | 32.303M 565.46% | 39.627M 1,967.14% | 45.492M 2,635.54% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 3.596M 119.99% | 11.722M 137.06% | 27.099M 480.66% | 33.435M 1,937.48% | 36.89M 925.86% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | 0.08 -98.97% | -0.45 | 0.53 | 117.78% |
| Q2 2023 Q2Q % growth | -0.14 79.41% | -0.52 | 0.38 | 73.02% |
| Q1 2023 Q2Q % growth | -0.77 -32.76% | -0.66 | -0.11 | -16.57% |
| Q4 2022 Q2Q % growth | -0.50 59.35% | -0.16 | -0.34 | -203.66% |
| Q3 2022 Q2Q % growth | 7.80 1,338.10% | 4.70 | 3.10 | 66.01% |
| Q2 2022 Q2Q % growth | -0.68 -106.06% | -0.50 | -0.18 | -36.76% |
| Q1 2022 Q2Q % growth | -0.58 52.46% | -0.92 | 0.34 | 36.95% |
| Q4 2021 Q2Q % growth | -1.23 22.15% | -1.12 | -0.11 | -9.94% |
| Q3 2021 Q2Q % growth | -0.63 60.87% | -1.11 | 0.48 | 43.37% |
| Q2 2021 Q2Q % growth | -0.33 82.81% | -1.24 | 0.91 | 73.43% |
| Q1 2021 Q2Q % growth | -1.22 57.34% | -1.47 | 0.25 | 17.08% |
| Q4 2020 Q2Q % growth | -1.58 47.16% | -1.50 | -0.08 | -5.09% |
| Q3 2020 Q2Q % growth | -1.61 37.84% | -1.97 | 0.36 | 18.30% |
| Q2 2020 Q2Q % growth | -1.92 15.79% | -2.97 | 1.05 | 35.44% |
| Q1 2020 Q2Q % growth | -2.86 5.61% | -2.96 | 0.10 | 3.38% |
| Q4 2019 Q2Q % growth | -2.99 | -2.72 | -0.27 | -9.83% |
| Q3 2019 Q2Q % growth | -2.59 | -2.48 | -0.11 | -4.34% |
| Q2 2019 Q2Q % growth | -2.28 | -2.65 | 0.37 | 14.02% |
| Q1 2019 Q2Q % growth | -3.03 | -2.58 | -0.45 | -17.66% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | 88.789M 14.44% | 90.28M | -1.491M | -1.65% |
| Q2 2023 Q2Q % growth | 83.718M 16.67% | 81.158M | 2.56M | 3.15% |
| Q1 2023 Q2Q % growth | 67.958M 14.90% | 73.664M | -5.706M | -7.75% |
| Q4 2022 Q2Q % growth | 77.219M 12.51% | 79.638M | -2.419M | -3.04% |
| Q3 2022 Q2Q % growth | 77.588M 16.43% | 75.549M | 2.039M | 2.70% |
| Q2 2022 Q2Q % growth | 71.757M 5.25% | 97.639M | -25.882M | -26.51% |
| Q1 2022 Q2Q % growth | 59.146M -27.57% | 91.5M | -32.354M | -35.36% |
| Q4 2021 Q2Q % growth | 68.633M -17.58% | 94.233M | -25.6M | -27.17% |
| Q3 2021 Q2Q % growth | 66.64M -16.20% | 84.676M | -18.036M | -21.30% |
| Q2 2021 Q2Q % growth | 68.178M -11.74% | 84.338M | -16.16M | -19.16% |
| Q1 2021 Q2Q % growth | 81.66M 12.40% | 82.839M | -1.179M | -1.42% |
| Q4 2020 Q2Q % growth | 83.27M 16.46% | 86.706M | -3.436M | -3.96% |
| Q3 2020 Q2Q % growth | 79.52M 28.36% | 80.202M | -682K | -0.85% |
| Q2 2020 Q2Q % growth | 77.25M 16.52% | 73.592M | 3.658M | 4.97% |
| Q1 2020 Q2Q % growth | 72.65M 39.04% | 71.055M | 1.595M | 2.24% |
| Q4 2019 Q2Q % growth | 71.5M | 69.756M | 1.744M | 2.50% |
| Q3 2019 Q2Q % growth | 61.95M | 64.444M | -2.494M | -3.87% |
| Q2 2019 Q2Q % growth | 66.3M | 59.848M | 6.452M | 10.78% |
| Q1 2019 Q2Q % growth | 52.25M | 53.021M | -771K | -1.45% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 660.22% | 0% | 3.74% |
| Revenue | 0% | 0.01% | 0% | 0.24% |